DETECTING LEAD RELATED CONDITION DURING DELIVERY OF THERAPEUTIC ELECTRICAL SIGNALS

• US 20110098765A1
• Filed: 10/27/2009
• Published: 04/28/2011
• Est. Priority Date: 10/27/2009
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Patel, Amisha S.
• Application Number:
  US12/606,891
• Publication Number:
  US 20110098765A1
• Time in Patent Office: Days
• US Class Current: 607/8
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/39622 Pacing therapy
• CPC Class Codes: A61N 2001/083 Monitoring integrity of contacts, e.g. by impedance measurement

Abstract

In general, the disclosure describes techniques for detecting lead related conditions, such as lead fractures or other lead integrity issues. As described herein, lead related conditions are identified by detecting delivered energy and electrical path impedance during delivery of a therapeutic electrical to a patient. If one or both of the delivered energy and impedance traverse respective thresholds, a lead related condition may exist. The energy delivered during the electrical signal may be compared to the amount of energy the electrical signal was programmed to deliver to determine if the delivered energy is less than a threshold percentage of the programmed energy of the electrical signal. The impedance of the electrical path through which the therapeutic electrical signal is delivered may be compared to a threshold impedance value to determine if the impedance detected during the electrical signal is greater than the threshold.

Claims

1. A method comprising:

delivering a therapeutic electrical signal to a patient via an electrical path including at least one medical lead;

detecting a delivered energy and an impedance of the path during the delivery of the electrical signal; and

identifying a lead related condition when at least one of the detected delivered energy and the detected impendence traverses a respective threshold.

2. The method of claim 1, wherein identifying a lead related condition when at least one of the detected delivered energy and the detected impendence traverses a threshold comprises identifying a lead related condition when both of the detected delivered energy and the detected impendence traverses a respective threshold.

3. The method of claim 1, wherein identifying the lead related condition comprises identifying the lead related condition when the detected energy is less than a percentage threshold of a programmed energy of the electrical signal.

4. The method of claim 3, wherein the percentage threshold of the programmed energy of the electrical signal is in a range from approximately 60% to approximately 80%.

5. The method of claim 4, wherein the percentage threshold of the programmed energy is approximately equal to 75%.

6. The method of claim 1, wherein identifying the lead related condition comprises identifying the lead related condition when the path impedance is greater than a threshold impedance value.

7. The method of claim 6, wherein the threshold impedance value is in a range from approximately 180 ohms to approximately 220 ohms.

8. The method of claim 7, wherein the threshold impedance value is approximately equal to 200 ohms.

9. The method of claim 1, wherein the therapeutic electrical signal comprises at least one of a pacing pulse configured to capture cardiac tissue, a defibrillation shock, or a cardioversion shock.

10. The method of claim 1, wherein the medical lead comprises an implantable medical lead.

11. The method of claim 1, further comprising generating an alert based on the identification of the lead related condition.

12. The method of claim 11, wherein the alert comprises at least one of an audible, text, graphical, device vibration, or light emission alert.

13. The method of claim 11, further comprising at least one of displaying or transmitting the alert.

14. The method of claim 1, further comprising determining a second electrical path configured to deliver the therapeutic electrical signal to the patient.

15. The method of claim 1, further comprising disabling the electrical path through which the therapeutic electrical signal is delivered.

16. A system comprising:

a medical lead;

a signal generator connected to the lead and configured to deliver a therapeutic electrical signal via an electrical path that includes the lead; and

a processor configured to detect a delivered energy and an impedance of the path during delivery of a therapeutic electrical signal to a patient and identify a lead related condition when at least one of the detected delivered energy and the detected impendence traverses a respective threshold.

17. The system of claim 16, wherein the processor identifies a lead related condition when both of the detected delivered energy and the detected impendence traverses a respective threshold.

18. The system of claim 16, wherein the processor identifies a lead related condition when the detected energy is less than a percentage threshold of a programmed energy of the electrical signal.

19. The system of claim 16, wherein the processor identifies a lead related condition when the path impedance is greater than a threshold impedance value.

20. The system of claim 16, wherein the therapeutic electrical signal comprises at least one of a pacing pulse configured to capture cardiac tissue, a defibrillation shock, or a cardioversion shock.

21. The system of claim 16, wherein the lead comprises an implantable medical lead, the system further comprising an implantable medical device that comprises the signal generator and the processor.

22. The system of claim 16, further comprising a programmer that comprises the processor.

23. The system of claim 16, further comprising the processor configured to generate an alert based on the identification of the lead related condition.

24. The system of claim 16, further comprising the processor configured to determine a second electrical path configured to deliver the therapeutic electrical signal to the patient.

25. The system of claim 16, further comprising the processor configured to disable the electrical path through which the therapeutic electrical signal is delivered.

26. A system comprising:

means for delivering a therapeutic electrical signal to a patient via an electrical path;

means for detecting a delivered energy and an impedance of the path during the delivery of the electrical signal; and

means for identifying a lead related condition when at least one of the detected delivered energy and the detected impendence traverses a respective threshold.

27. A computer-readable medium comprising instructions for causing a programmable processor to:

deliver a therapeutic electrical signal to a patient via an electrical path including at least one medical lead;

detect a delivered energy and an impedance of the path during the delivery of the electrical signal; and

identify a lead related condition when at least one of the detected delivered energy and the detected impendence traverses a respective threshold.